Metered-dose inhaler efficiency enhancement: A case study and novel design

References

• Barry PW, O’Callaghan C. 1997. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J 10:1345–1348.
   PubMed Web of Science ®Google Scholar
• Bowes SM, Swift DL. 1989. Deposition of Inhaled particles in the oral airway during oronasal breathing. Aerosol Sci Technol 11:157–167.
   Web of Science ®Google Scholar
• Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J. 2001. Comparison of the effectiveness of inhaler devices in asthma and chronic obstruction airway disease. Health Technol Assess 5:1–149.
   PubMedGoogle Scholar
• Chan TL, Lippmann M. 1980. Experimental measurement and empirical modeling of the regional deposition of inhaled particles in human. J Independ Hyg Assoc 41:399–409.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Zhou Y, Chen B. 1999. Particle deposition in a cast of human oral airways. Aerosol Sci Technol 31:286–300.
   Web of Science ®Google Scholar
• Cheng YS, Fu CS, Yazzie D, Zhou Y. 2001. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulation in a human airway replica. J Aerosol Med 14:255–266.
   PubMedGoogle Scholar
• Davis SS, Hardy JG, Newman SP, Wilding IR. 1992. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med Mol Imag 19:971–986.
   Web of Science ®Google Scholar
• Dehaan W, Finlay W. 2001. In In vitro Monodisperse aerosol deposition in a month and throat with six different inhalation devices. J Aerosol Med 14:361–367.
   PubMedGoogle Scholar
• Dehaan W, Finlay W. 2004. Predicting extrathoracic deposition from dry powder inhalers. J Aerosol Sci 35:309–331.
   Web of Science ®Google Scholar
• Emmett PC, Aitken RJ, Hannan WJ. 1982. Measurements of total and regional deposition of inhaled particles in the human respiratory tract. J Aerosol Science 13:549–560.
   Web of Science ®Google Scholar
• Foord N, Black A, Walsh M. 1978. Regional Deposition of 2.5 – 7.5 μm Diameter Inhaled Particles in Healthy Male Non-Smokers. Journal of Aerosol Sci 9:283–390.
   Google Scholar
• Fadl A, Wang J, Yang P, Zhang Z, Cheng Y. 2007a. Balloon based in vitro MDI aerosol deposition experiments on the effects of mouthpiece diameter. J Inhal Toxicol 19:505–515.
   PubMed Web of Science ®Google Scholar
• Fadl A, Wang J, Zhang Z, Cheng Y. 2007b. Effects of MDI spray angle on aerosol penetration efficiency through an oral airway cast. Int J Aerosol Sci 38:853–864.
   Web of Science ®Google Scholar
• Grgic B, Finlay WH, Heenan AF. 2004. Regional aerosol deposition and flow measurements in idealized mouth and throat. J Aerosol Sci 35:21–23.
   Web of Science ®Google Scholar
• Heenan AF, Finlay WH, Matida EA, Pollard A. 2003. Experimental measurements and computational modeling of the flow in an idealized extrathoracic airway. Exp Fluids 35:70–84.
   Web of Science ®Google Scholar
• Hochrainer D, Hölz H, Kreher C, Scaffidi L, Spallek M, Wachtel H. 2005. Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalers. J Aerosol Med 18:273–282.
   PubMedGoogle Scholar
• Johnson K. 1995. Inhalation drug delivery: Principles techniques and applications to product development. Notes for AAPS Short Course, Miami Beach, FL.
   Google Scholar
• Kim CS, Garcia L. 1993. Delivery characteristics of albuterol powder aerosol by rotahaler. J Aerosol Med 2:199–211.
   Google Scholar
• Lipmann M, Albert RE. 1969. The effect of particle size on the regional deposition of inhaled aerosol in the human respiratory tract. J Independ Hyg Assoc 30:257–275.
   PubMedGoogle Scholar
• Lin T, Breysse P, Laube B, Swift D. 2001. Mouthpiece diameter affects deposition efficiency in cast models of human oral airway. J Aerosol Med 14:335–341.
   PubMedGoogle Scholar
• Newman SP. 1985. Aerosol deposition considerations in inhalation therapy. Chest 88:125–160.
   Web of Science ®Google Scholar
• Newman SP, Clarke SW. 1983. Therapeutic aerosols. 1—Physical and practical considerations [editorial]. Thorax 38:881–886.
   PubMed Web of Science ®Google Scholar
• Newman SP, Clark AR, Talaee N, Clarks SW. 1989. Pressurized aerosol deposition in the human lung with and without an “open” spacer device. Thorax 44:706–710.
   PubMed Web of Science ®Google Scholar
• Newman SP, Brown J, Steed KP, Reader SJ, Kladders H. 1998. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices. Chest 113:957–963.
   PubMed Web of Science ®Google Scholar
• Stahilofen W, Gebhart J, Heyder J. 1980. Experimental determination of the regional deposition of aerosol in the human respiratory tract. J Independ Hyg Assoc 41:385–395.
   PubMedGoogle Scholar
• Stahilofen W, Gebhart J, Heyder J, Scheuch G. 1983. New regional deposition date of the human respiratory tract. J Aerosol Med 2:285–308.
   Google Scholar
• Swift DL. 1989. Design of aerosol delivery system to optimize regional deposition and agent utilization. J Aerosol Med 2:211–220.
   Google Scholar
• Yu CP, Diu CK. 1983. Total and regional deposition of inhaled aerosol in humans. J Aerosol Sci 14:599–609.
   Web of Science ®Google Scholar
• Yue G, Fadl A, Barek T, Major J, Zhang Z. 2009. Experimental study of aerosol deposition in pulsating balloon structures. J Inhal Toxicol 21:215–222.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chia TL, Finlay WH, 2006. Experimental measurements and numerical study of particle deposition in highly idealized mouth-throat models. Aerosol Sci Technol 40:361–372.
   Web of Science ®Google Scholar